Impact of chemoprophylaxis with pentamidine or co-trimoxazole in HIV-positive patients on the incidence of bacterial pneumonia;Inzidenz bakterieller Pneumonien bei HIV-positiven Patienten unter Chemoprophylaxe mit Co-trimoxazol oder Pentamidin

Pneumologie

Volumn 52, Issue 11, 1998, Pages 614-621

  Koch, A ^a   Kothe, H ^a   Braun, J ^a   Kammerer R ^a   Friedrich, H J ^a   Dalhoff, K ^a,b  

^a UNIVERSITY OF LÜBECK   (Germany)

^b Medizinische Klinik II   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIPROTOZOAL AGENT; COTRIMOXAZOLE; PENTAMIDINE; SULFONAMIDE;

ARTICLE; BACTERIAL PNEUMONIA; CHEMOPROPHYLAXIS; HAEMOPHILUS INFLUENZAE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INCIDENCE; INFECTION RISK; INHALATIONAL DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; STAPHYLOCOCCUS AUREUS; STATISTICAL ANALYSIS; STREPTOCOCCUS PNEUMONIAE; TOXOPLASMOSIS;

ADULT; AIDS-RELATED OPPORTUNISTIC INFECTIONS; ANTI-INFECTIVE AGENTS; ANTIFUNGAL AGENTS; CD4 LYMPHOCYTE COUNT; FEMALE; HUMANS; MALE; MIDDLE AGED; ODDS RATIO; PENTAMIDINE; PNEUMONIA, BACTERIAL; PNEUMONIA, PNEUMOCYSTIS; RETROSPECTIVE STUDIES; RISK; TOXOPLASMOSIS, CEREBRAL; TREATMENT OUTCOME; TRIMETHOPRIM-SULFAMETHOXAZOLE COMBINATION;

EID: 0031751220     PISSN: 09348387     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Agostini, C., L. Trentin, R. Zambello, G. Semenzato: HIV-1 and the Lung. Infectivity, Pathogenic Mechanism, and Cellular Immune Responses taking place in the lower respiratory tract. Am. Rev. Respir. Dis. 147 (1993) 1038-1049
2. Ahmed, F., M. C. Steinhoff, M. C. Rodriguez-Barradas, R. G. Hamilton, D. M. Musher, K. E. Nelson: Effect of Human Immunodeficiency Virus Type 1 Infection on the antibody response to a Glycoprotein conjugate pneumococcal vaccine: results from a randomized trial. J. Infect. Dis. 173 (1996) 83-90
3. Aries, S. P., B. Schaaf, F. Hansen, K. Weyrich, V. Kurowsky, R. Dennin, K. Dalhoff: Expression of complement receptors and regulatory proteins on alveolar CD4+ lymphocytes from human immunodeficiency virus-1 infected individuals. Eur. Respir. J. 10 (1997) 1736-1741
4. Bozzette, S. A., D. M. Finkelstein, St. A. Spector, P. Frame, W. G. Powderly, W. He, L. Phillips, D. Craven, Ch. Van der Horst, J. A. Feinberg: A randomized trial of three antipneumocystis agents in patients with advanced HIV. N. Engl. J. Med. 332 (1995) 693-699
5. Breimann, R. F., J. C. Butler, F. C. Tenover, J. A. Elliott, R. F. Facklam: Emergence of drug-resistant penumococcal infections in the United states. JAMA 271 (1994) 1831-1835
6. Bucher, H. C., L. Griffth, G. H. Guyatt, M. Opravi: Meta-analyses of prophylactic treatments against PCP and Toxoplasma encephalitis in HIV-infected patients. J. Acquir. Immune. Defic. Syndr. Hum. Retrovirol. 15 (1997) 104-114
7. Burack, J. H., J. A. Hahn, D. Saint-Maurice, M. A. Jacobson: Microbiology of Community acquired bacterial pneumonia in persons with AIDS and at risk for HIV-Type 1 Infection. Arch. Intern. Med. 154 (1994) 2589-2596
8. Caiffa, W. T., N. M. H. Graham, D. Vlahov: Bacterial Pneumonia in adult populations with Human Immundeficiency Virus (HIV) Infection. Am. J. Epidemiol. 138 (1993) 909-922
9. Carson, P. J., R. L. Schut, M. L. Simpson, J. O'Brien, E. D. Janoff: Antibody class and subclass responses to pneumococcal polysaccharides following immunization of Human Immunodeficiency virus-infected patients. J. Infect. Dis. 172 (1995) 340-345
10. Centers for Disease Control: Recommendations of the immunization practices advisory committee: Pneumococcal Polysaccharide Vaccine. M. M. W. R. CDC Surveillance Summaries 38 (1989) 64-76
11. Clerici, M., G. M. Shearer: The Th1-Th2 hypothesis of HIV infection: new insights. Immunology Today 15 (1994) 575-581
12. Cohn, D. L.: Bacteriel pneumonia in HIV-infected patient. Infect. Dis. Clin. N. Am. 5 (1991) 485-507
13. Daley, Ch. L.: Pyogenic bacterial pneumonia in acquired immunodeficiency syndrome. J. Thorax. Imaging. 6 (1991) 36-42
14. Demaurex, N., V. Gabriel, R. Auckenthaler: The efficacy of pneumococcal vaccination in HIV seropositive patients (HIV+): a case control study. VIII International conference on AIDS. Amsterdam, Netherlands, June 21-25, 1992: B239 (Abst. PoB 3890)
15. Ewig, S.: The effect of Prophylaxis on the outcome of HIV-associated PCP. Chest 109 (1996) 586-587
16. Frankel, R. E., M. Virata, C. Hardalo, F. L. Altice, G. Friedland: Invasive pneumococcal disease: Clinical features, serotypes, and antimicrobial resistance patterns in cases involving patients with and without Human Immunodeficiency Virus Infection. Clin. Inf. Dis. 23 (1996) 577-584
17. Gallant, J. E., R. D. Moore, R. E. Chaisson: Prophylaxis for opportunistic infections in patients with HIV-Infection. Ann. Intern. Med. 120 (1994) 932-944
18. Garcà-Leoni, M. E., S. Moreno, P. Rode, E. Cercenado, T. Vocente, E. Bouza: Pneumococcal pneumonia in adult hospitalized patients infected with human immunodeficiency virus. Arch. Intern. Med. 152 (1992) 1808-1812
19. Galser, J. B., S. Volpe, A. Aguirre, H. Simpkins, G. Schiffman: Zidovudine improves response to pneumococcal vaccine among persons with AIDS and AIDS-related complex. J. Infect. Dis. 164 (1991) 761-764
20. Grünberg, R. N.: The Alexander Procect: using in-vitro susceptibility data for choosing empirical therapy in LRTI. J. Antimicrob. Chemother. 38 Suppl. A (1996) 155-170
21. Hardy, W. D., J. Feinberg, D. M. Finkelstein, M. E. Power, W. He, C. Kaczka, P. T. Frame, M. Holmes, H. Waskin, R. J. Fass, W. G. Powderly, R. T. Steibigel, A. Zuger, R. A. Holzman: A controlled trial of trimethoprim-sulfamethoxazol or aerolized pentamidine for secondary prophylaxis of pneumocystis carinii pneumonia in patients with the Acquired Immunodeficiency Syndrome. N. Engl. J. Med. 327 (1992) 1842-1848
22. Hirschtick, R. E., J. Glassroth, M. C. Jordan, T. C. Wilcosky, J.-M. Wallace, P. A. Kvale, N. Markowitz, M. Rosen, B. T. Mangura, P. C. Hopewell: Bacterial Pneumonia in persons with the Human Immunodeficiency Virus. N. Engl. J. Med. 33 (1995) 845-851
23. Huang, K. L., F. L. Ruben, C. R. Rinaldo, L. Kingsley, D. W. Lyter, M. Ho: Antibody responses after influenza and pneumococcal immunization in HIV infected homosexual men. JAMA 257 (1987) 2047-2050
24. Janoff, E. N., R. F. Breiman, Ch. L. Daley, Ph. C. Hopewell: Pneumococcal disease during HIV-Infection. Epidemiologic clinical and immunologic perspectives. Annals of Internal Medicine 117 (1992) 314-322
25. Klech, H.: Technical recommandations and guidelines for bronchoalveolar lavage (BAL): Report of the European Society of Pneumology Task Group on BAL. Eur. Resp. J. 2 (1989) 561-585
26. Kovacs, J. A.: Diagnosis, treatment and prevention of Pneumocystis carinii-pneumonia in HIV-infected patients. AIDS Updates March/April 2 (1989) 1-12
27. Li-ares, J., J. L. Perez, L. Murgui, R. Mart'n: Comperative susceptibilities of penicillin-resistant pneumococci to co-trimoxazole, vancomycin, rifampicin and fourteen β-lactam antibiotics. J. Antimicrob. Chemother. 13 (1984) 353-359
28. Luft, B. J., J. S. Remington: Toxoplasmic encephalitis. Clin. Infect. Dis. 15 (1992) 211-222
29. Magnenat, J. L., L. P. Nicod, R. Auckenthaler, A. Junod: Mode of presentation and diagnosis of bacterial pneumonia in Human Immunodeficiency Virus-infected patients. Am. Rev. Respir. Dis. 144 (1991) 917-922
30. Murray, J. F.: Pulmonary complications of HIV-infection. Ann. Rev. Med. 47 (1996) 117-126
31. Musher, D. M.: Streptococcus Pneumoniae: Prevention. In: Mandell, G. L., J. E. Bennett, R. J. E. Dolin (Hrsg.): Principles and Practice of Infectious Diseases. Churchill Livingstone (1995) 1811-1826
32. Polsky, B., J. W. M. Gold, E. Whimbey, J. Dryjansky, A. E. Brown, G. Schiffmann, D. Armstrong: Bacterial pneumonia in patients with the Immunodeficiency Syndrome. Ann. Int. Med. 104 (1986) 38-41
33. Rodriguez-Barradas, M. C., D. M. Musher, C. Lahart, C. Lacke, J. Groover, D. Watson, R. Baughn, T. Cate, G. Crofoot: Antibody to capsular polysaccharides of Streptococcus pneumoniae after vaccination of human immunodeficiency virus-infected subjects with 23-valent pneumococcal vaccine. J. Infect. Dis. 16 (1992) 553-565
34. Sachs, L.: Relatives Risiko und Chancen-Verhältnis (Odds Ratio). In: Angewandte Statistik. 7. Aufl., Springer Verlag, Berlin (1992) 311-316
35. Schito, G. C., E. A. Debbia, A. Pesce und die Alexander Collaborative Group: Susceptibility of respiratory strains of staphylococcus aureus to fifteen antibiotics: results of a collaborative surveillance study (1992-1993) 97-105
36. Schneider, M. M. E., A. I. M. Hoepelman, J. K. M. Eeftinck Schattenkerk, T. L. Nielson, Y. van der Graaf, J. P. H. J. Frissen, I. E. M. Van der Ende, A. F. P. Kolsters, J. C. C. Borleffs: A controlled trial of aerosolized pentamidine or trimethoprim-sulfamethoxazole as primary prophylaxis against PCP in patients with HIV. N. Engl. J. Med. 327 (1992) 1836-1841
37. Simberkoff, M., W. E. Sadr, G. Schiffman, J. J. Rahal Jr.: Streptococcus pneumoniae infections and bacteriemia in patients with Acquired Immunodeficiency Syndrome, with report of a pneumococcal vaccine failure. Am. Rev. Respir. Dis. 130 (1984) 1174-1176
38. Wallace, J.-M., A. V. Rao, J. Glassroth, N. I. Hansen, M. J. Rosen, C. Arakaki, P. A. Kvale, L. B. Reichman, P. C. Hopewell: Respiratory Illness in persons with Human Immunodeficiency Virus Infection. Am. Rev. Respir. Dis. 148 (1993) 1523-1529
39. Wallace, J.-M., N. I. Hansen, L. Lavange, J. Glassroth, B. L. Browdy, M. J. Rosen, P. A. Kvale, B. T. Mangura, L. B. Reichmann, P. C. Hoppewell: Respiratory Disease trends in the pulmonary complications of HIV Infected Study cohort. Am. J. Resp. Crit. Care Med. 155 (1997) 72-80